Amgen Surges to 71st in Trading Volume with $15.62 Billion Day

On May 30, 2025, Amgen's trading volume reached $15.62 billion, marking a significant 97.43% increase from the previous day. This surge placed Amgen at the 71st position in terms of trading volume for the day. The stock price of Amgen rose by 1.64%, marking the second consecutive day of gains, with a total increase of 3.51% over the past two days.

Amgen is set to present at the Jefferies Global Healthcare Conference on June 4, 2025. The presentation will be led by Peter Griffith, the executive vice president and chief financial officer, and Murdo Gordon, the executive vice president of Global Commercial Operations. The event will be webcast live and available for replay on Amgen's website for at least 90 days following the conference. This presentation is part of Amgen's ongoing efforts to communicate its business developments and innovations to investors and the public.

Amgen's participation in the Jefferies Global Healthcare Conference is expected to provide valuable insights into the company's strategic direction and recent advancements. The conference offers a platform for Amgen to highlight its pipeline of innovative medicines and its commitment to addressing some of the world's most challenging diseases. This event is likely to attract significant attention from investors and industry analysts, potentially influencing market sentiment towards Amgen's stock.